Page last updated: 2024-10-22

theophylline and Scleroderma, Systemic

theophylline has been researched along with Scleroderma, Systemic in 2 studies

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verbenko, EV1
Goncharova, LI1
Petrova, IL1
Shamina, GE1
Skopinska-Rózewska, E1
Majewski, S1
Błaszczyk, M1
Włodarska, B1
Jabłońska, S1

Other Studies

2 other studies available for theophylline and Scleroderma, Systemic

ArticleYear
[Use of complamin in some dermatoses].
    Vestnik dermatologii i venerologii, 1975, Issue:8

    Topics: Adolescent; Adult; Aged; Arteritis; Drug Evaluation; Eczema; Erythema; Female; Humans; Lichen Planus

1975
Theophylline-resistant and theophylline-sensitive "active" and "total" E rosette-forming lymphocytes in patients with systemic scleroderma.
    The Journal of investigative dermatology, 1988, Volume: 90, Issue:6

    Topics: Adult; Aged; Drug Resistance; Female; Humans; Male; Middle Aged; Rosette Formation; Scleroderma, Sys

1988